Stockscreener 앱 받기
24.35
1.88%
0.45
전일 마감가:
$23.90
열려 있는:
$23.93
하루 거래량:
3.01M
Relative Volume:
0.46
시가총액:
$12.59B
수익:
$11.32B
순이익/손실:
$-981.00M
주가수익비율:
-12.47
EPS:
-1.9532
순현금흐름:
$714.00M
1주 성능:
+3.66%
1개월 성능:
-0.16%
6개월 성능:
+40.75%
1년 성능:
+8.17%
1일 변동 폭
$23.84
$24.46
1주일 범위
$23.23
$24.60
52주 변동 폭
$15.73
$30.00
박스터 인터내셔널 Stock (BAX) Company Profile
명칭
Baxter International Inc
전화
(224) 948-2000
주소
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, RMD, MDLN, ALC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
24.35 | 12.59B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
423.96 | 149.78B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.75 | 50.05B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
230.05 | 32.35B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
36.26 | 31.81B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
64.11 | 30.99B | 10.63B | 819.00M | 1.59B | 1.6577 |
박스터 인터내셔널 Stock (BAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-10-07 | 개시 | Barclays | Underweight |
| 2026-07-31 | 업그레이드 | Citigroup | Sell → Neutral |
| 2026-05-28 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-10-31 | 다운그레이드 | Argus | Buy → Hold |
| 2025-08-04 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-08-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-02-26 | 재개 | Goldman | Buy |
| 2025-02-24 | 업그레이드 | Argus | Hold → Buy |
| 2025-02-20 | 재개 | Barclays | Overweight |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-15 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-06-24 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-18 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-18 | 재확인 | Raymond James | Outperform |
| 2022-02-18 | 재확인 | Stifel | Buy |
| 2022-02-18 | 재확인 | UBS | Neutral |
| 2022-02-18 | 재확인 | Wells Fargo | Overweight |
| 2022-02-11 | 개시 | Goldman | Neutral |
| 2022-01-07 | 재개 | Citigroup | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-09-03 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-09-04 | 다운그레이드 | Argus | Buy → Hold |
| 2020-06-24 | 개시 | Oppenheimer | Outperform |
| 2020-03-19 | 업그레이드 | Stifel | Hold → Buy |
| 2020-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-01-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-01-02 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | 업그레이드 | Argus | Hold → Buy |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-05-17 | 재개 | Piper Jaffray | Overweight |
| 2018-02-06 | 재확인 | Citigroup | Neutral |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
모두보기
박스터 인터내셔널 주식(BAX)의 최신 뉴스
Baxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors - FinancialContent
BAX Initiates Coverage On Baxter International -- Rating Set to Underweight - GuruFocus
Evercore ISI Adjusts Price Target on Baxter International to $32 From $24 - marketscreener.com
Barclays Initiates Coverage on Baxter International With Underweight Rating, $20 Price Target - www.marketscreener.com
Baxter International Inc. (BAX) Stock Forecasts - Yahoo Finance
Citigroup cuts target for Baxter International stock from USD 28.00 to USD 27.00 - AD HOC NEWS
Baxter International Price Target Cut to $27.00/Share From $28.00 by Citigroup - Moomoo
Citigroup Trims Price Target on Baxter International to $27 From $28, Keeps Neutral Rating - Moomoo
Are Investors Undervaluing Baxter International (BAX) Right Now? - Zacks Investment Research
Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year? - Zacks Investment Research
Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Are Investors Undervaluing Baxter International (BAX) Right Now? - Yahoo Finance
Citigroup cuts target for Baxter International stock to USD 27.00 - AD HOC NEWS
Baxter International Inc (BAX) Stock Up 3.1% and Still Undervalued -- GF Score: 70/100 - GuruFocus
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Zacks cuts Baxter estimate and Baxter International stock gains 1.49 percent - AD HOC NEWS
Baxter Releases Inaugural Connected Hospital Report - Bioscience Association Manitoba
Citigroup Trims Price Target on Baxter International to $27 From $28, Keeps Neutral Rating - marketscreener.com
BAX5072770 Bond Profile: Coupon and Redemption - TradingView
BAX.GQ Bond Profile: Coupon and Redemption - TradingView
Baxter International stock after-hours at EUR 20.82: minus 0.95 percent versus prior close - AD HOC NEWS
Can Execution Lift Baxter International (NYSE:BAX) From Here? - Kalkine Media
BAX5072771 Bond Profile: Coupon and Redemption - tradingview.com
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
What Investors Might Be Missing On Baxter International (BAX) - Yahoo Finance
Baxter Releases Inaugural Connected Hospital Report - Business Wire
Why Investors Need to Take Advantage of These 2 Medical Stocks Now - Zacks Investment Research
Baxter International stock trades above analyst target - ad-hoc-news.de
Baxter International stock heads into the open after a 1.9 percent S&P 500 drop - AD HOC NEWS
Here's Why You Should Retain Baxter Stock in Your Portfolio for Now - TradingView
Here's Why You Should Retain Baxter Stock in Your Portfolio for Now - Yahoo Finance
Veterinary Ophthalmology Equipment Market by Product, Animal Type, Application, End User, Region Report Forecasts Market to Reach USD 0.83 Billion by 2031, Growing at a 7.7% CAGR - GlobeNewswire Inc.
Baxter International stock holds at USD 22.93 as storm damage weighs - AD HOC NEWS
A Look at Baxter International Inc (BAX) After 3.3% Gain -- GF V - GuruFocus
A Look at Baxter International Inc (BAX) After 3.3% Gain -- GF V - GuruFocus
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter plant's Helene recovery has a human face - The Asheville Citizen Times
Is Baxter Stock Underperforming the Nasdaq? - Yahoo Finance
Top 3 Health Care Stocks That May Rocket Higher In September - Benzinga
Baxter International Inc. (BAX) Stock Analysis: Assessing a 26% Potential Upside Amid Healthcare Sector Challenges - DirectorsTalk Interviews
Baxter International (BAX) Q2 2026 Earnings Call Transcript - Fortune
Baxter International (BAX) Q1 2026 Earnings Call Transcript - Fortune
Baxter International Inc Share PriceBAX, RNS News, Articles, Quotes, & Charts (NYSE:BAX) - Proactive financial news
Securities Lawsuit Alert: Baxter International, Inc. (BAX) – Contact Levi & Korsinsky Before December 15, 2025 - ACCESS Newswire
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter International stock heads into the open after a modest gain - ad-hoc-news.de
Intravenous Immunoglobulin Market Size Worth USD 30.83 Billion by 2035, Growing at 7.49% CAGR – SNS Insider - GlobeNewswire Inc.
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Transcript : Baxter International Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 12 - marketscreener.com
Baxter at Wells Fargo conference: growth improves as turnaround continues By Investing.com - Investing.com UK
박스터 인터내셔널 (BAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
6.13%
1.17%
자본화:
|
볼륨(24시간):